Skip to main content

Daniel Lliboutry Capdevila

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Daniel Lliboutry Capdevila

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Ana Lucea Peña

Ana Lucea Peña

Postdoctoral researcher
Donation and transplantation of organs, tissues and cells
Read more
Cleofé Romagosa Pérez-Portabell

Cleofé Romagosa Pérez-Portabell

Main researcher
Translational Molecular Pathology
Read more
Anna Martinez Lacalle

Anna Martinez Lacalle

Research technician
Nephrology and kidney transplantation
Read more
Ingrid Galán Cartaña

Ingrid Galán Cartaña

Senior researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.